Harpoon Therapeutics Inc (HARP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES

Harpoon Therapeutics, Inc. operates as a biotechnology company. The Company develops novel class T cell that unleash the natural power of the T cells to fight cancer and other diseases. Harpoon Therapeutics serves patients in the States of Massachusetts and California.

Q1 2019 All Institutions Hedge Funds 1
To trade HARP now:
Filers who had this stock in their top 10: 2 2 (0.2%)
13F Filers holding this stock: 29 8 (0.82%)
Aggregate 13F shares on 03/31/2019: 12.191 Million 11.53 Million
Aggregate 13F shares on 12/31/2018: 0
Percent change:
Funds creating new positions: 28 8
Funds Adding to an existing position:
Funds closing out their position:
Funds reducing their position:
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding HARP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCMAHON GERALD PHD PRESIDENT AND CEO

  • Officer
  • Director
3,000 2019-05-14 3

BAEUERLE PATRICK

  • Director
0 2019-04-11 1

HUNT RONALD

  • Director
  • 10% Owner
1,543,962 2019-04-01 1

EVNIN LUKE

  • Director
  • 10% Owner
322,063 2019-02-07 1

EASTLAND JULIA MARIE

  • Director
0 2019-02-07 1

DRACHMAN JONATHAN G

  • Director
0 2019-02-07 1

CHIN MARK

  • Director
  • 10% Owner
0 2019-02-07 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MCMAHON GERALD PHD - Director - Officer PRESIDENT AND CEO

2019-05-14 P 1,000 $10.16 a 3,000 3,000.00 direct

MCMAHON GERALD PHD - Director - Officer PRESIDENT AND CEO

2019-05-08 P 1,000 $10.56 a 2,000 2,000.00 direct

MCMAHON GERALD PHD - Director - Officer PRESIDENT AND CEO

2019-05-03 P 1,000 $10.53 a 1,000 1,000.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments